444 related articles for article (PubMed ID: 31916049)
1. Deep neural network affinity model for BACE inhibitors in D3R Grand Challenge 4.
Wang B; Ng HL
J Comput Aided Mol Des; 2020 Feb; 34(2):201-217. PubMed ID: 31916049
[TBL] [Abstract][Full Text] [Related]
2. D3R Grand Challenge 4: ligand similarity and MM-GBSA-based pose prediction and affinity ranking for BACE-1 inhibitors.
Sasmal S; El Khoury L; Mobley DL
J Comput Aided Mol Des; 2020 Feb; 34(2):163-177. PubMed ID: 31781990
[TBL] [Abstract][Full Text] [Related]
3. D3R grand challenge 4: blind prediction of protein-ligand poses, affinity rankings, and relative binding free energies.
Parks CD; Gaieb Z; Chiu M; Yang H; Shao C; Walters WP; Jansen JM; McGaughey G; Lewis RA; Bembenek SD; Ameriks MK; Mirzadegan T; Burley SK; Amaro RE; Gilson MK
J Comput Aided Mol Des; 2020 Feb; 34(2):99-119. PubMed ID: 31974851
[TBL] [Abstract][Full Text] [Related]
4. Sampling and refinement protocols for template-based macrocycle docking: 2018 D3R Grand Challenge 4.
Kotelnikov S; Alekseenko A; Liu C; Ignatov M; Padhorny D; Brini E; Lukin M; Coutsias E; Dill KA; Kozakov D
J Comput Aided Mol Des; 2020 Feb; 34(2):179-189. PubMed ID: 31879831
[TBL] [Abstract][Full Text] [Related]
5. Comparison of affinity ranking using AutoDock-GPU and MM-GBSA scores for BACE-1 inhibitors in the D3R Grand Challenge 4.
El Khoury L; Santos-Martins D; Sasmal S; Eberhardt J; Bianco G; Ambrosio FA; Solis-Vasquez L; Koch A; Forli S; Mobley DL
J Comput Aided Mol Des; 2019 Dec; 33(12):1011-1020. PubMed ID: 31691919
[TBL] [Abstract][Full Text] [Related]
6. Predicting binding poses and affinity ranking in D3R Grand Challenge using PL-PatchSurfer2.0.
Shin WH; Kihara D
J Comput Aided Mol Des; 2019 Dec; 33(12):1083-1094. PubMed ID: 31506789
[TBL] [Abstract][Full Text] [Related]
7. MathDL: mathematical deep learning for D3R Grand Challenge 4.
Nguyen DD; Gao K; Wang M; Wei GW
J Comput Aided Mol Des; 2020 Feb; 34(2):131-147. PubMed ID: 31734815
[TBL] [Abstract][Full Text] [Related]
8. D3R Grand Challenge 4: prospective pose prediction of BACE1 ligands with AutoDock-GPU.
Santos-Martins D; Eberhardt J; Bianco G; Solis-Vasquez L; Ambrosio FA; Koch A; Forli S
J Comput Aided Mol Des; 2019 Dec; 33(12):1071-1081. PubMed ID: 31691920
[TBL] [Abstract][Full Text] [Related]
9. Computational Modeling of β-Secretase 1 (BACE-1) Inhibitors Using Ligand Based Approaches.
Subramanian G; Ramsundar B; Pande V; Denny RA
J Chem Inf Model; 2016 Oct; 56(10):1936-1949. PubMed ID: 27689393
[TBL] [Abstract][Full Text] [Related]
10. Study on the active mechanism of β-secretase inhibitors by molecular simulations.
Tian YL; Lv M; Li JJ; Xu T; Zhai HL; Zhang XY
Eur J Pharm Sci; 2015 Aug; 76():138-48. PubMed ID: 25965961
[TBL] [Abstract][Full Text] [Related]
11. Effect of pH and ligand charge state on BACE-1 fragment docking performance.
Domínguez JL; Villaverde MC; Sussman F
J Comput Aided Mol Des; 2013 May; 27(5):403-17. PubMed ID: 23640428
[TBL] [Abstract][Full Text] [Related]
12. Coupling enhanced sampling of the apo-receptor with template-based ligand conformers selection: performance in pose prediction in the D3R Grand Challenge 4.
Basciu A; Koukos PI; Malloci G; Bonvin AMJJ; Vargiu AV
J Comput Aided Mol Des; 2020 Feb; 34(2):149-162. PubMed ID: 31720895
[TBL] [Abstract][Full Text] [Related]
13. Docking, molecular dynamics, binding energy-MM-PBSA studies of naphthofuran derivatives to identify potential dual inhibitors against BACE-1 and GSK-3β.
Kumar A; Srivastava G; Negi AS; Sharma A
J Biomol Struct Dyn; 2019 Feb; 37(2):275-290. PubMed ID: 29310523
[TBL] [Abstract][Full Text] [Related]
14. Affinity prediction using deep learning based on SMILES input for D3R grand challenge 4.
Lim S; Lee YO; Yoon J; Kim YJ
J Comput Aided Mol Des; 2022 Mar; 36(3):225-235. PubMed ID: 35314897
[TBL] [Abstract][Full Text] [Related]
15. The role of human in the loop: lessons from D3R challenge 4.
Stroganov OV; Novikov FN; Medvedev MG; Dmitrienko AO; Gerasimov I; Svitanko IV; Chilov GG
J Comput Aided Mol Des; 2020 Feb; 34(2):121-130. PubMed ID: 31965405
[TBL] [Abstract][Full Text] [Related]
16. Structure-based design and synthesis of macrocyclic peptidomimetic beta-secretase (BACE-1) inhibitors.
Machauer R; Veenstra S; Rondeau JM; Tintelnot-Blomley M; Betschart C; Neumann U; Paganetti P
Bioorg Med Chem Lett; 2009 Mar; 19(5):1361-5. PubMed ID: 19195886
[TBL] [Abstract][Full Text] [Related]
17. Macrocyclic BACE inhibitors: Optimization of a micromolar hit to nanomolar leads.
Huang Y; Strobel ED; Ho CY; Reynolds CH; Conway KA; Piesvaux JA; Brenneman DE; Yohrling GJ; Moore Arnold H; Rosenthal D; Alexander RS; Tounge BA; Mercken M; Vandermeeren M; Parker MH; Reitz AB; Baxter EW
Bioorg Med Chem Lett; 2010 May; 20(10):3158-60. PubMed ID: 20399652
[TBL] [Abstract][Full Text] [Related]
18. Dynamic Simulation, Docking and DFT Studies Applied to a Set of Anti-Acetylcholinesterase Inhibitors in the enzyme β-Secretase (BACE-1): An Important Therapeutic Target in Alzheimer`s disease.
Silva-Junior EF; Barcellos Franca PH; Quintans-Junior LJ; Mendonca-Junior FJB; Scotti L; Scotti MT; de Aquino TM; de Araujo-Junior JX
Curr Comput Aided Drug Des; 2017 Nov; 13(4):266-274. PubMed ID: 28382866
[TBL] [Abstract][Full Text] [Related]
19. Retrospective molecular docking study of WY-25105 ligand to β-secretase and bias of the three-dimensional structure flexibility.
Ghemtio L; Muzet N
J Mol Model; 2013 Aug; 19(8):2971-9. PubMed ID: 23564327
[TBL] [Abstract][Full Text] [Related]
20. Unveiling a novel transient druggable pocket in BACE-1 through molecular simulations: Conformational analysis and binding mode of multisite inhibitors.
Di Pietro O; Juárez-Jiménez J; Muñoz-Torrero D; Laughton CA; Luque FJ
PLoS One; 2017; 12(5):e0177683. PubMed ID: 28505196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
